Antibiotic Therapy for Prosthetic Joint Infections

Introduction to Antibiotic Regimens

• The American College of Cardiology and Infectious Diseases Society of America recommend Ciprofloxacin (250-500 mg PO twice daily) for excellent coverage against Proteus species, with good bioavailability and tissue penetration, and can be used for long-term suppression 1, 2
• The Infectious Diseases Society of America suggests alternative options, including Trimethoprim-sulfamethoxazole (1 double-strength tablet twice daily) 3, Amoxicillin-clavulanate (875/125 mg twice daily) 1, 4, and Doxycycline (100 mg twice daily) 5
• The IDSA recommends targeting beta-hemolytic streptococci with antibiotic therapy, and for suspected MRSA, considering clindamycin or trimethoprim-sulfamethoxazole 6, 5

Duration of Suppressive Therapy

• The Infectious Diseases Society of America recommends that suppressive therapy should be continued indefinitely as long as the infected hardware remains in place, with a moderate strength of evidence 2, 3
• The duration of therapy should be based on infection severity, with mild infections treated for 7-10 days, moderate infections treated for 10-14 days, and severe infections treated for 14-21 days, as recommended by the IDSA 7, 8
• The following table outlines the recommended duration for different types of infections:

9

Management of Infected Wounds

• Elevation of the affected limb is recommended to reduce swelling and promote healing, and systemic corticosteroids may be considered in non-diabetic adults, such as prednisone 40mg daily for 7 days 6, 5
• Patients should be instructed to return if symptoms worsen, fever develops, or if the area of erythema expands, and should keep the area clean and dry, with warm compresses to help with residual inflammation 5
• Adjunctive therapy, including wound care and debridement, evaluation of vascular status, and offloading pressure for diabetic foot wounds, is essential for effective management of infected wounds, as recommended by the IDSA 7

Prevention and Complications

• Keeping the skin well hydrated with emollients, treating interdigital maceration and tinea pedis, and providing meticulous skin care are essential for preventing cellulitis, according to the IDSA 6, 5
• Compression therapy, such as stockings or pneumatic pumps, and elevation of the affected limb are recommended to manage lymphedema, a potential complication of cellulitis 6
• The IDSA recommends prophylactic antibiotics, such as oral penicillin V or erythromycin, for patients with ≥3-4 episodes per year despite addressing predisposing factors, and continuing prophylaxis as long as predisposing factors persist 6, 5

Special Considerations

• The overuse of broad-spectrum antibiotics contributes to antimicrobial resistance 5
• Patients allergic to penicillins may have cross-reactivity with cephalosporins, and the risk of cross-reactivity between amoxicillin and cephalexin specifically remains a concern, as noted by the IDSA 10, 11
• In pregnancy, amoxicillin-clavulanate is classified as Category B and is generally considered safe, as stated by the American College of Obstetricians and Gynecologists (ACOG) 12
• In nursing mothers, amoxicillin-clavulanate should be used with caution as the drug is distributed in milk, as recommended by the American Academy of Pediatrics (AAP) 12
• Hospitalization is recommended for severely compromised patients, such as those with significant comorbidities or severe infections, as suggested by the IDSA 11
• Dose adjustment for renal impairment is recommended when using antibiotics such as amoxicillin-clavulanate and cefazolin in patients with chronic kidney disease (CKD), as stated by the IDSA 13

Treatment Failure and Surgical Consultation

• If infection fails to respond to initial therapy, consider discontinuing all antibiotics, obtaining optimal culture specimens, and restarting targeted therapy based on culture results, as recommended by the IDSA 8
• Surgical consultation is needed for deep abscess, extensive necrosis, crepitus, or necrotizing fasciitis, as recommended by the IDSA 8